Glutamate, Interleukin-6, and Early Clinical Worsening in Patients With Acute Stroke
Author(s) -
Nicolás Vila,
Ángel Chamorro,
José Castillo,
Antonio Dávalos
Publication year - 2001
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.32.5.1234-a
Subject(s) - medicine , stroke (engine) , acute stroke , interleukin , cardiology , intensive care medicine , cytokine , tissue plasminogen activator , mechanical engineering , engineering
To the Editor: We appreciate Dr Christensen’s interest in our work, recently published in Stroke .1 As we stated in the Subjects and Methods section of that article, the 231 patients analyzed in our study were selected form a larger cohort of 249 patients admitted consecutively between October 1992 and December 1996. Shrewdly, Christensen correctly guesses that this larger cohort includes the 128 patients that supported our report on glutamate excitotoxicity in acute ischemic stroke.2 Therefore, this larger series gives additional ground and further credit to the role of glutamate and IL-6 on neurological deterioration in patients with ischemic stroke.The concentrations …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom